Compounds > canrenone
Page last updated: 2024-08-21

canrenone and Left Ventricular Dysfunction

canrenone has been researched along with Left Ventricular Dysfunction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlocco, E; Bertolini, A; Grandi, AM; Guasti, L; Imperiale, D; Santillo, R; Venco, A1
Casaburi, C; Cittadini, A; Di Gianni, A; Isgaard, J; Monti, MG; Saccà, L; Saldamarco, L; Serpico, R; Strömer, H; Vanasia, M1
Boccanelli, A; Cacciatore, G; Clemenza, F; De Maria, R; de Simone, G; Di Lenarda, A; Gavazzi, A; Gonzini, L; Latini, R; Maggioni, AP; Masson, S; Mureddu, GF; Porcu, M; Vanasia, M1

Trials

2 trial(s) available for canrenone and Left Ventricular Dysfunction

ArticleYear
Aldosterone antagonist improves diastolic function in essential hypertension.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Canrenone; Diastole; Drug Administration Schedule; Echocardiography; Heart; Heart Rate; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Left

2002
Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
    Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:9

    Topics: Aged; Aldosterone; Biomarkers; Canrenone; Disease Progression; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ventricular Dysfunction, Left; Ventricular Remodeling

2007

Other Studies

1 other study(ies) available for canrenone and Left Ventricular Dysfunction

ArticleYear
Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.
    Cardiovascular research, 2003, Jun-01, Volume: 58, Issue:3

    Topics: Animals; Calcium-Transporting ATPases; Canrenone; Drug Therapy, Combination; Heart Failure; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Norepinephrine; Ramipril; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Dysfunction, Left; Ventricular Remodeling

2003